Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies
Authors:
- Farbod ShojaeiFSFarbod Shojaei
- Napoleone FerraraNFNapoleone Ferrara
- 1 December 2008
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 11 (6) , 219-230
Abstract
No abstract availableKeywords
This publication has 159 references indexed in Scilit:
- Modes of resistance to anti-angiogenic therapyNature Reviews Cancer, 2008
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and InvasionCancer Cell, 2008
- Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic CellsCancer Cell, 2008
- Dendritic cells and cytokines in human inflammatory and autoimmune diseasesCytokine & Growth Factor Reviews, 2008
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote MetastasisCancer Cell, 2008
- Angiogenesis in implantationJournal of Assisted Reproduction and Genetics, 2007
- Genes that Distinguish Physiological and Pathological AngiogenesisCancer Cell, 2007
- The biology of VEGF and its receptorsNature Medicine, 2003
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993